AFFIMED N.V. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.81 USD | +0.21% |
|
-11.58% | -23.04% |
| Apr. 01 | Wells Fargo Cuts Affimed Price Target to $25 From $30, Maintains Overweight Rating | MT |
| Apr. 01 | HC Wainwright Adjusts Affimed's Price Target to $10 From $50, Maintains Buy Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AFFIMED N.V. | Bio Therapeutic Drugs | +0.21% | -11.58% | -23.04% | -50.22% | -83.97% | 73.09M |  |  | |
- Stock Market
- Equities
- AFMD Stock
- Charts Affimed N.V.
- Relative Strength Chart
